InnovAge Holding Corp.

The Company provided a subordinated loan to SH1 and provided a guarantee for a convertible term loan held by SH1.

SEC original ↗InnovAge Holding Corp. — 10-Q Quarterly report10-QMay 8, 2026

The Company s investment in InnovAge Sacramento includes a put right for the noncontrolling interest holders to require the Company to repurchase the interest of the noncontrolling interest holders at fair value, after the initial term of the management services agreement in 2028.

SEC original ↗InnovAge Holding Corp. — 10-Q Quarterly report10-QMay 8, 2026

As most of the Company's leases do not provide an implicit rate, the Company uses its incremental borrowing rate based on the information available at commencement date in determining the present value of future payments.

SEC original ↗InnovAge Holding Corp. — 10-Q Quarterly report10-QMay 8, 2026

Long-Term Debt Long-term debt consisted of the following at March 31, 2026 and June 30, 2025: March 31, 2026 June 30, 2025 in thousands Senior secured borrowings: Term Loan Facility $ 49,446 $ 60,000 Revolving Credit Facility 9,368 Total debt 58,814 60,000 Less: unamortized debt issuance costs 846 286 Less: current maturities 2,536 2,250 Noncurrent maturities $ 55,432 $ 57,464 Credit Agreement On March 8, 2021, the Company entered into a credit agreement (as amended, the Credit Agreement ) that replaced its prior credit agreement.

SEC original ↗InnovAge Holding Corp. — 10-Q Quarterly report10-QMay 8, 2026

The Credit Agreement consisted of a senior secured term loan (the Term Loan Facility ) of $ 75.0 million principal amount and a revolving credit facility (the Revolving Credit Facility ) of $ 100.0 million maximum borrowing capacity.

SEC original ↗InnovAge Holding Corp. — 10-Q Quarterly report10-QMay 8, 2026

2 refinanced the Term Loan Facility with a $ 50.7 million term loan (the "Term Loan A Facility"), renewed the commitments with respect to the Revolving Credit Facility and extended the maturity date of both the Term Loan A Facility and the Revolving Credit Facility to August 8, 2028 from March 8, 2026.

SEC original ↗InnovAge Holding Corp. — 10-Q Quarterly report10-QMay 8, 2026

Costs reflected consist of litigation costs considered one-time in nature and outside of the ordinary course of business based on the following considerations which we assess regularly (i) the frequency of similar cases that have been brought to date, or are expected to be brought within two years, (ii) complexity of the case, (iii) nature of the remedies sought, (iv) litigation posture of the Company, (v) counterparty involved, and (vi) the Company's overall litigation strategy.

SEC original ↗InnovAge Holding Corp. — Earnings release (8-K exhibit)EX-99Sep 9, 2025

(d) Reflects charges related to business optimization initiatives.

SEC original ↗InnovAge Holding Corp. — Earnings release (8-K exhibit)EX-99Sep 9, 2025

For the year ended June 30, 2024, this includes (i) $3.1 million of costs associated with third party consultants to implement core provider initiatives, assess our risk-bearing capabilities, and strengthen our enterprise capabilities, (ii) $0.3 million of costs associated with organizational restructure, and (iii) $0.9 million related to other non-recurring projects aimed at reducing costs and improving efficiencies.

SEC original ↗InnovAge Holding Corp. — Earnings release (8-K exhibit)EX-99Sep 9, 2025

For the three months ended June 30, 2025, this includes $2.1 million of costs associated with third party consultants to implement core provider initiatives, assess our risk-bearing capabilities, and strengthen our enterprise capabilities.

SEC original ↗InnovAge Holding Corp. — Earnings release (8-K exhibit)EX-99Sep 9, 2025

For the three months ended June 30, 2024, costs include (i) $0.5 million in third party consultants to implement our core provider initiatives, assess our risk-bearing payor capabilities, and strengthen our enterprise capabilities and (ii) $0.2 million in fees associated with the Pinewood Lodge, LLLP (PWD ) dissolution.

SEC original ↗InnovAge Holding Corp. — Earnings release (8-K exhibit)EX-99Sep 9, 2025

Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control and may cause our actual results and financial condition to differ materially.

SEC original ↗InnovAge Holding Corp. — Earnings release (8-K exhibit)EX-99Sep 9, 2025

We define Adjusted EBITDA as net loss adjusted for interest expense, net, other investment income, depreciation and amortization, and provision (benefit) for income tax as well as addbacks for non-recurring expenses or exceptional items, including charges relating to management equity compensation, litigation costs and settlement, M A diligence, transaction and integration, business optimization, electronic medical record (EMR) implementation, gain (loss) on cost and equity method investments, asset impairments and loss on sale of assets.

SEC original ↗InnovAge Holding Corp. — Earnings release (8-K exhibit)EX-99Sep 9, 2025

(b) Reflects charges (credits) related to litigation by stockholders, litigation related to de novo center, civil investigative demands, and arbitration with our former pharmacy provider.

SEC original ↗InnovAge Holding Corp. — Earnings release (8-K exhibit)EX-99Sep 9, 2025

Costs reflected consist of litigation costs considered one-time in nature and outside of the ordinary course of business based on the following considerations which we assess regularly (i) the frequency of similar cases that have been brought to date, or are expected to be brought within two years, (ii) complexity of the case, (iii) nature of the remedies sought, (iv) litigation posture of the Company, (v) counterparty involved, and (vi) the Company's overall litigation strategy.

SEC original ↗InnovAge Holding Corp. — Earnings release (8-K exhibit)EX-99Sep 9, 2025

Three Months Ended March 31, 2025 Net Loss $ (11,133) Interest expense, net 1,160 Other investment income (a) (503) Depreciation and amortization 5,386 Provision for income tax 72 Stock-based compensation 2,035 Litigation costs and settlement (b) 13,277 M A diligence, transaction and integration (c) 202 Business optimization (d) 152 EMR implementation (e) Loss on cost and equity method investments (f) Asset impairments and loss on assets held for sale (g) 144 Adjusted EBITDA $ 10,792 Net loss margin (5.8) % Adjusted EBITDA margin 5.6 % _______________________ (a) Reflects investment income related to short term investments included in our consolidated statement of operations.

SEC original ↗InnovAge Holding Corp. — Earnings release (8-K exhibit)EX-99Sep 9, 2025

(b) Reflects charges (credits) related to litigation by stockholders, litigation related to de novo center, and civil investigative demands.

SEC original ↗InnovAge Holding Corp. — Earnings release (8-K exhibit)EX-99Sep 9, 2025